{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:54:10Z","timestamp":1793685250415,"version":"4.5.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004869","name":"Universit\u00e4t M\u00fcnster","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004869","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Restoring impaired peripheral immune tolerance is the primary challenge in treating autoimmune diseases. Our previous research demonstrated the effectiveness of small spleen peptides (SSPs), a fraction of low molecular weight proteins, in inhibiting the progression of psoriatic arthritis, even in the presence of high levels of the proinflammatory cytokine TNF\u03b1 in the bloodstream. When specifically targeting dendritic cells (DCs), SSPs transform them into tolerogenic cells, which efficiently induce the development of regulatory Foxp3<jats:sup>+<\/jats:sup> Treg cells. In this study, we provide further insights into the mechanism of action of SSPs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that SSPs stimulate the activation of the mTOR signaling pathway in dendritic cells, albeit in a different manner than the classical immunogenic stimulus LPS. While LPS-induced activation is rapid, strong, and sustained, the activity induced by SSPs is delayed, less intense, yet still significant. These distinct patterns of activation, as measured by phosphorylation of key components of the pathway are also observed in response to other immunogenic and tolerogenic stimuli such as GM-CSF\u2009+\u2009IL-4 or IL-10 and TGF\u03b2. The disparity in mTOR activation between immunogenic and tolerogenic stimuli is quantitative rather than qualitative. In both cases, mTOR activation primarily occurs through the PI3K\/Akt signaling axis and involves ERK and GSK3\u03b2 kinases, with minimal involvement of AMPK or NF-kB pathways. Furthermore, in the case of SSPs, mTOR activation seems to involve adenosine receptors. Additionally, we observed that DCs treated with SSPs exhibit an energy metabolism with high plasticity, which is typical of tolerogenic cells rather than immunogenic cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Hence, the decision whether dendritic cells enter an inflammatory or tolerogenic state seems to rely on varying activation thresholds and kinetics of the mTOR signaling pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12964-024-01655-1","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:01:59Z","timestamp":1716289319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Conversion of dendritic cells into tolerogenic or inflammatory cells depends on the activation threshold and kinetics of the mTOR signaling pathway"],"prefix":"10.1186","volume":"22","author":[{"given":"Viktor","family":"Wixler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Boergeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Leite Dantas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"1655_CR1","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/1873-3468.12711","volume":"591","author":"M Linke","year":"2017","unstructured":"Linke M, Fritsch SD, Sukhbaatar N, Hengstschlager M, Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett. 2017;591:3089\u2013103.","journal-title":"FEBS Lett"},{"key":"1655_CR2","doi-asserted-by":"crossref","unstructured":"Nouwen LV, Everts B. Pathogens MenTORing macrophages and dendritic cells: manipulation of mTOR and cellular metabolism to promote immune escape. Cells. 2020;9:161.","DOI":"10.3390\/cells9010161"},{"key":"1655_CR3","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.it.2016.08.009","volume":"37","author":"N Sukhbaatar","year":"2016","unstructured":"Sukhbaatar N, Hengstschlager M, Weichhart T. mTOR-mediated regulation of dendritic cell differentiation and function. Trends Immunol. 2016;37:778\u201389.","journal-title":"Trends Immunol"},{"key":"1655_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;169:361\u201371.","journal-title":"Cell"},{"key":"1655_CR5","doi-asserted-by":"publisher","first-page":"3589","DOI":"10.1242\/jcs.051011","volume":"122","author":"M Laplante","year":"2009","unstructured":"Laplante M, Sabatini DM. mTOR signaling at a glance. J Cell Sci. 2009;122:3589\u201394.","journal-title":"J Cell Sci"},{"key":"1655_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41392-023-01608-z","volume":"8","author":"V Panwar","year":"2023","unstructured":"Panwar V, Singh A, Bhatt M, Tonk RK, Azizov S, Raza AS, Sengupta S, Kumar D, Garg M. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. Signal Transduct Target Therapy. 2023;8:375.","journal-title":"Signal Transduct Target Therapy"},{"key":"1655_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1742-2094-11-44","volume":"11","author":"Q Lu","year":"2014","unstructured":"Lu Q, Gao L, Huang L, Ruan L, Yang J, Huang W, Li Z, Zhang Y, Jin K, Zhuge Q. Inhibition of mammalian target of rapamycin improves neurobehavioral deficit and modulates immune response after intracerebral hemorrhage in rat. J Neuroinflamm. 2014;11:44.","journal-title":"J Neuroinflamm"},{"key":"1655_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12967-016-0916-7","volume":"14","author":"G Stallone","year":"2016","unstructured":"Stallone G, Infante B, Di Lorenzo A, Rascio F, Zaza G, Grandaliano G. mTOR inhibitors effects on regulatory T cells and on dendritic cells. J Translational Med. 2016;14:152.","journal-title":"J Translational Med"},{"key":"1655_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13578-020-00396-1","volume":"10","author":"Z Zou","year":"2020","unstructured":"Zou Z, Tao T, Li H, Zhu X. mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges. Cell Bioscience. 2020;10:31.","journal-title":"Cell Bioscience"},{"key":"1655_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi M, Hall MN. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol. 2014;15:155\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1655_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/1756-9966-28-152","volume":"28","author":"L Xiao","year":"2009","unstructured":"Xiao L, Wang YC, Li WS, Du Y. The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray. J Experimental Clin cancer Research: CR. 2009;28:152.","journal-title":"J Experimental Clin cancer Research: CR"},{"key":"1655_CR12","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.ymthe.2021.08.030","volume":"30","author":"V Wixler","year":"2022","unstructured":"Wixler V, Zaytsev IZ, Leite Dantas R, Schied T, Boergeling Y, Luhrmann V, Varga G, Masemann D, Ludwig S. Small spleen peptides prevent development of psoriatic arthritis via restoration of peripheral tolerance. Mol Therapy: J Am Soc Gene Therapy. 2022;30:745\u201362.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"1655_CR13","doi-asserted-by":"crossref","unstructured":"Gerlt V, Mayr J, Del Sarto J, Ludwig S, Boergeling Y. Cellular protein phosphatase 2A regulates cell survival mechanisms in influenza a virus infection. Int J Mol Sci. 2021;22:11164.","DOI":"10.3390\/ijms222011164"},{"key":"1655_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell. 2002;10:151\u201362.","journal-title":"Mol Cell"},{"key":"1655_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1478-811X-12-29","volume":"12","author":"A Hillesheim","year":"2014","unstructured":"Hillesheim A, Nordhoff C, Boergeling Y, Ludwig S, Wixler V. beta-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza a virus-induced RIG-I\/NF-kappaB signaling. Cell Communication Signaling: CCS. 2014;12:29.","journal-title":"Cell Communication Signaling: CCS"},{"key":"1655_CR16","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1074\/jbc.M109.040667","volume":"285","author":"T Sunami","year":"2010","unstructured":"Sunami T, Byrne N, Diehl RE, Funabashi K, Hall DL, Ikuta M, Patel SB, Shipman JM, Smith RF, Takahashi I, et al. Structural basis of human p70 ribosomal S6 kinase-1 regulation by activation loop phosphorylation. J Biol Chem. 2010;285:4587\u201394.","journal-title":"J Biol Chem"},{"key":"1655_CR17","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3389\/fimmu.2019.00775","volume":"10","author":"SK Wculek","year":"2019","unstructured":"Wculek SK, Khouili SC, Priego E, Heras-Murillo I, Sancho D. Metabolic control of dendritic cell functions: digesting information. Front Immunol. 2019;10:775.","journal-title":"Front Immunol"},{"key":"1655_CR18","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s13238-010-0123-x","volume":"1","author":"D Gao","year":"2010","unstructured":"Gao D, Wan L, Wei W. Phosphorylation of Rictor at Thr1135 impairs the Rictor\/Cullin-1 complex to ubiquitinate SGK1. Protein Cell. 2010;1:881\u20135.","journal-title":"Protein Cell"},{"key":"1655_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3109\/10409239409083485","volume":"29","author":"S Ferrari","year":"1994","unstructured":"Ferrari S, Thomas G. S6 phosphorylation and the p70s6k\/p85s6k. Crit Rev Biochem Mol Biol. 1994;29:385\u2013413.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"1655_CR20","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1101\/gad.13.11.1422","volume":"13","author":"AC Gingras","year":"1999","unstructured":"Gingras AC, Gygi SP, Raught B, Polakiewicz RD, Abraham RT, Hoekstra MF, Aebersold R, Sonenberg N. Regulation of 4E-BP1 phosphorylation: a novel two-step mechanism. Genes Dev. 1999;13:1422\u201337.","journal-title":"Genes Dev"},{"key":"1655_CR21","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1101\/gad.1212704","volume":"18","author":"N Hay","year":"2004","unstructured":"Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004;18:1926\u201345.","journal-title":"Genes Dev"},{"key":"1655_CR22","doi-asserted-by":"crossref","unstructured":"Melick CH, Jewell JL. Regulation of mTORC1 by upstream stimuli. Genes. 2020;11:989.","DOI":"10.3390\/genes11090989"},{"key":"1655_CR23","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1038\/s41467-022-29368-4","volume":"13","author":"A Levina","year":"2022","unstructured":"Levina A, Fleming KD, Burke JE, Leonard TA. Activation of the essential kinase PDK1 by phosphoinositide-driven trans-autophosphorylation. Nat Commun. 2022;13:1874.","journal-title":"Nat Commun"},{"key":"1655_CR24","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.1106148","volume":"307","author":"DD Sarbassov","year":"2005","unstructured":"Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. Phosphorylation and regulation of Akt\/PKB by the rictor-mTOR complex. Science. 2005;307:1098\u2013101.","journal-title":"Science"},{"key":"1655_CR25","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ncb1547","volume":"9","author":"E Vander Haar","year":"2007","unstructured":"Vander Haar E, Lee SI, Bandhakavi S, Griffin TJ, Kim DH. Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40. Nat Cell Biol. 2007;9:316\u201323.","journal-title":"Nat Cell Biol"},{"key":"1655_CR26","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.4161\/cc.6.24.5085","volume":"6","author":"DF Lee","year":"2007","unstructured":"Lee DF, Hung MC. All roads lead to mTOR: integrating inflammation and tumor angiogenesis. Cell Cycle. 2007;6:3011\u20134.","journal-title":"Cell Cycle"},{"key":"1655_CR27","first-page":"633","volume":"22","author":"DF Lee","year":"2008","unstructured":"Lee DF, Kuo HP, Chen CT, Wei Y, Chou CK, Hung JY, Yen CJ, Hung MC. IKKbeta suppression of TSC1 function links the mTOR pathway with insulin resistance. Int J Mol Med. 2008;22:633\u20138.","journal-title":"Int J Mol Med"},{"key":"1655_CR28","doi-asserted-by":"publisher","first-page":"30353","DOI":"10.1074\/jbc.274.43.30353","volume":"274","author":"H Sakurai","year":"1999","unstructured":"Sakurai H, Chiba H, Miyoshi H, Sugita T, Toriumi W. IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem. 1999;274:30353\u20136.","journal-title":"J Biol Chem"},{"key":"1655_CR29","doi-asserted-by":"publisher","first-page":"806521","DOI":"10.3389\/fcell.2021.806521","volume":"9","author":"E Fidalgo da Silva","year":"2021","unstructured":"Fidalgo da Silva E, Fong J, Roye-Azar A, Nadi A, Drouillard C, Pillon A, Porter LA. Beyond protein synthesis; the multifaceted roles of Tuberin in cell cycle regulation. Front cell Dev Biology. 2021;9:806521.","journal-title":"Front cell Dev Biology"},{"key":"1655_CR30","doi-asserted-by":"publisher","first-page":"6687","DOI":"10.1128\/MCB.16.12.6687","volume":"16","author":"S Ludwig","year":"1996","unstructured":"Ludwig S, Engel K, Hoffmeyer A, Sithanandam G, Neufeld B, Palm D, Gaestel M, Rapp UR. 3pK, a novel mitogen-activated protein (MAP) kinase-activated protein kinase, is targeted by three MAP kinase pathways. Mol Cell Biol. 1996;16:6687\u201397.","journal-title":"Mol Cell Biol"},{"key":"1655_CR31","doi-asserted-by":"crossref","unstructured":"Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare Mannelli L, Pugliese AM, Salvemini D. Uncovering the mechanisms of adenosine receptor-mediated pain control: focus on the A(3) receptor subtype. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22157952"},{"key":"1655_CR32","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","volume":"13","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol. 2011;13:1016\u201323.","journal-title":"Nat Cell Biol"},{"key":"1655_CR33","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","volume":"148","author":"E Beurel","year":"2015","unstructured":"Beurel E, Grieco SF, Jope RS. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacol Ther. 2015;148:114\u201331.","journal-title":"Pharmacol Ther"},{"key":"1655_CR34","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.cell.2006.06.055","volume":"126","author":"K Inoki","year":"2006","unstructured":"Inoki K, Ouyang H, Zhu T, Lindvall C, Wang Y, Zhang X, Yang Q, Bennett C, Harada Y, Stankunas K, et al. TSC2 integrates wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell. 2006;126:955\u201368.","journal-title":"Cell"},{"key":"1655_CR35","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.cell.2006.08.025","volume":"126","author":"AY Choo","year":"2006","unstructured":"Choo AY, Roux PP, Blenis J. Mind the GAP: wnt steps onto the mTORC1 train. Cell. 2006;126:834\u20136.","journal-title":"Cell"},{"key":"1655_CR36","doi-asserted-by":"crossref","unstructured":"Mancinelli R, Carpino G, Petrungaro S, Mammola CL, Tomaipitinca L, Filippini A, Facchiano A, Ziparo E, Giampietri C. Multifaceted roles of GSK-3 in cancer and autophagy-related diseases. Oxidative Med Cell Longev. 2017;2017:4629495.","DOI":"10.1155\/2017\/4629495"},{"key":"1655_CR37","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1128\/MCB.17.9.5648","volume":"17","author":"BA Moser","year":"1997","unstructured":"Moser BA, Dennis PB, Pullen N, Pearson RB, Williamson NA, Wettenhall RE, Kozma SC, Thomas G. Dual requirement for a newly identified phosphorylation site in p70s6k. Mol Cell Biol. 1997;17:5648\u201355.","journal-title":"Mol Cell Biol"},{"key":"1655_CR38","doi-asserted-by":"publisher","first-page":"119059","DOI":"10.1016\/j.bbamcr.2021.119059","volume":"1868","author":"D Papadopoli","year":"2021","unstructured":"Papadopoli D, Pollak M, Topisirovic I. The role of GSK3 in metabolic pathway perturbations in cancer. Biochim et Biophys acta Mol cell Res. 2021;1868:119059.","journal-title":"Biochim et Biophys acta Mol cell Res"},{"issue":"Pt 1","key":"1655_CR39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1042\/bj2960015","volume":"296","author":"C Sutherland","year":"1993","unstructured":"Sutherland C, Leighton IA, Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J. 1993;296(Pt 1):15\u20139.","journal-title":"Biochem J"},{"key":"1655_CR40","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3389\/fimmu.2020.00122","volume":"11","author":"A Suryawanshi","year":"2020","unstructured":"Suryawanshi A, Hussein MS, Prasad PD, Manicassamy S. Wnt Signaling Cascade in dendritic cells and regulation of anti-tumor immunity. Front Immunol. 2020;11:122.","journal-title":"Front Immunol"},{"key":"1655_CR41","doi-asserted-by":"publisher","first-page":"9971","DOI":"10.1074\/jbc.M508778200","volume":"281","author":"S Taurin","year":"2006","unstructured":"Taurin S, Sandbo N, Qin Y, Browning D, Dulin NO. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase. J Biol Chem. 2006;281:9971\u20136.","journal-title":"J Biol Chem"},{"key":"1655_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1074\/jbc.M113.469239","volume":"289","author":"Y Borgeling","year":"2014","unstructured":"Borgeling Y, Schmolke M, Viemann D, Nordhoff C, Roth J, Ludwig S. Inhibition of p38 mitogen-activated protein kinase impairs influenza virus-induced primary and secondary host gene responses and protects mice from lethal H5N1 infection. J Biol Chem. 2014;289:13\u201327.","journal-title":"J Biol Chem"},{"key":"1655_CR43","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.3389\/fimmu.2019.01265","volume":"10","author":"N Lotfi","year":"2019","unstructured":"Lotfi N, Thome R, Rezaei N, Zhang GX, Rezaei A, Rostami A, Esmaeil N. Roles of GM-CSF in the pathogenesis of autoimmune diseases: an update. Front Immunol. 2019;10:1265.","journal-title":"Front Immunol"},{"key":"1655_CR44","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3109\/08923973.2012.665461","volume":"34","author":"C Saponaro","year":"2012","unstructured":"Saponaro C, Cianciulli A, Calvello R, Dragone T, Iacobazzi F, Panaro MA. The PI3K\/Akt pathway is required for LPS activation of microglial cells. Immunopharmacol Immunotoxicol. 2012;34:858\u201365.","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1655_CR45","doi-asserted-by":"publisher","first-page":"14262","DOI":"10.1074\/jbc.RA120.014994","volume":"295","author":"S Maity","year":"2020","unstructured":"Maity S, Das F, Kasinath BS, Ghosh-Choudhury N, Ghosh Choudhury G. TGFbeta acts through PDGFRbeta to activate mTORC1 via the Akt\/PRAS40 axis and causes glomerular mesangial cell hypertrophy and matrix protein expression. J Biol Chem. 2020;295:14262\u201378.","journal-title":"J Biol Chem"},{"key":"1655_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/cr.2008.328","volume":"19","author":"YE Zhang","year":"2009","unstructured":"Zhang YE. Non-smad pathways in TGF-beta signaling. Cell Res. 2009;19:128\u201339.","journal-title":"Cell Res"},{"key":"1655_CR47","doi-asserted-by":"crossref","unstructured":"Saraiva M, Vieira P, O\u2019Garra A. Biology and therapeutic potential of interleukin-10. J Exp Med. 2020;217:e20190418.","DOI":"10.1084\/jem.20190418"},{"key":"1655_CR48","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4049\/jimmunol.1401024","volume":"194","author":"YP Zhu","year":"2015","unstructured":"Zhu YP, Brown JR, Sag D, Zhang L, Suttles J. Adenosine 5\u2019-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages. J Immunol. 2015;194:584\u201394.","journal-title":"J Immunol"},{"key":"1655_CR49","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3390\/biom14040469","volume":"14","author":"V Wixler","year":"2024","unstructured":"Wixler V, Leite Dantas R, Varga G, Boergeling Y, Ludwig S. Small spleen peptides (SSPs) shape dendritic cell differentiation through modulation of extracellular ATP synthesis profile. Biomolecules. 2024;14:469.","journal-title":"Biomolecules"},{"key":"1655_CR50","doi-asserted-by":"publisher","first-page":"767785","DOI":"10.3389\/fendo.2021.767785","volume":"12","author":"Y Xing","year":"2021","unstructured":"Xing Y, Ye Y, Zuo H, Li Y. Progress on the function and application of Thymosin beta4. Front Endocrinol. 2021;12:767785.","journal-title":"Front Endocrinol"},{"key":"1655_CR51","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1096\/fj.10-169417","volume":"25","author":"KW Freeman","year":"2011","unstructured":"Freeman KW, Bowman BR, Zetter BR. Regenerative protein thymosin beta-4 is a novel regulator of purinergic signaling. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2011;25:907\u201315.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"},{"key":"1655_CR52","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.tips.2016.02.006","volume":"37","author":"PA Borea","year":"2016","unstructured":"Borea PA, Gessi S, Merighi S, Varani K. Adenosine as a Multi-signalling guardian angel in human diseases: when, where and how does it exert its Protective effects? Trends Pharmacol Sci. 2016;37:419\u201334.","journal-title":"Trends Pharmacol Sci"},{"key":"1655_CR53","doi-asserted-by":"crossref","unstructured":"Pasquini S, Contri C, Borea PA, Vincenzi F, Varani K. Adenosine and inflammation: here, there and everywhere. Int J Mol Sci. 2021;22:7685.","DOI":"10.3390\/ijms22147685"},{"key":"1655_CR54","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.3389\/fimmu.2018.02581","volume":"9","author":"C Silva-Vilches","year":"2018","unstructured":"Silva-Vilches C, Ring S, Mahnke K. ATP and its metabolite adenosine as regulators of dendritic cell activity. Front Immunol. 2018;9:2581.","journal-title":"Front Immunol"},{"key":"1655_CR55","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nrd1983","volume":"5","author":"KA Jacobson","year":"2006","unstructured":"Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discovery. 2006;5:247\u201364.","journal-title":"Nat Rev Drug Discovery"},{"key":"1655_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/jphp.12844","volume":"70","author":"A Bahreyni","year":"2018","unstructured":"Bahreyni A, Khazaei M, Rajabian M, Ryzhikov M, Avan A, Hassanian SM. Therapeutic potency of pharmacological adenosine receptor agonist\/antagonist in angiogenesis, current status and perspectives. J Pharm Pharmacol. 2018;70:191\u20136.","journal-title":"J Pharm Pharmacol"},{"key":"1655_CR57","doi-asserted-by":"publisher","first-page":"304","DOI":"10.3389\/fimmu.2014.00304","volume":"5","author":"A Ohta","year":"2014","unstructured":"Ohta A, Sitkovsky M. Extracellular adenosine-mediated modulation of regulatory T cells. Front Immunol. 2014;5:304.","journal-title":"Front Immunol"},{"key":"1655_CR58","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"CM Krawczyk","year":"2010","unstructured":"Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, Cross JR, Jung E, Thompson CB, Jones RG, Pearce EJ. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115:4742\u20139.","journal-title":"Blood"},{"key":"1655_CR59","doi-asserted-by":"publisher","first-page":"5174","DOI":"10.4049\/jimmunol.1303316","volume":"194","author":"F Malinarich","year":"2015","unstructured":"Malinarich F, Duan K, Hamid RA, Bijin A, Lin WX, Poidinger M, Fairhurst AM, Connolly JE. High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells. J Immunol. 2015;194:5174\u201386.","journal-title":"J Immunol"},{"key":"1655_CR60","first-page":"203","volume":"5","author":"B Everts","year":"2014","unstructured":"Everts B, Pearce EJ. Metabolic control of dendritic cell activation and function: recent advances and clinical implications. Front Immunol. 2014;5:203.","journal-title":"Front Immunol"},{"key":"1655_CR61","doi-asserted-by":"publisher","first-page":"13106","DOI":"10.1096\/fj.202000767R","volume":"34","author":"P Marchetti","year":"2020","unstructured":"Marchetti P, Fovez Q, Germain N, Khamari R, Kluza J. Mitochondrial spare respiratory capacity: mechanisms, regulation, and significance in non-transformed and cancer cells. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2020;34:13106\u201324.","journal-title":"FASEB Journal: Official Publication Federation Am Soc Experimental Biology"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01655-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-024-01655-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-024-01655-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T11:03:49Z","timestamp":1716289429000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-024-01655-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1655"],"URL":"https:\/\/doi.org\/10.1186\/s12964-024-01655-1","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]},"assertion":[{"value":"10 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"281"}}